This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Double-Blind Placebo Study on Magnetic Field Therapy in Chronic Lumbar Pain

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2007 by Weintraub, Michael I., MD, FACP, FAAN.
Recruitment status was:  Recruiting
Steven P. Cole, PhD.
Information provided by:
Weintraub, Michael I., MD, FACP, FAAN Identifier:
First received: December 1, 2006
Last updated: September 20, 2007
Last verified: September 2007

This project is to assess the effectiveness of the use of magnets in reducing chronic lumbar pain. I understand that I will wear a flex pad (magnet) during waking hours and keep daily Visual Analog Scale (VAS) pain scores to determine if wearing this device will reduce my constant pain. I understand that there are no adverse side effects known from the use of these magnets other than irritation at the site. The identical inactive pads (sham/placebo) have been supplied for use as controls.

I will be randomly assigned into one of two groups and I agree to remain blinded as to the specific type of device that I will receive, i.e. active vs. placebo. Dr. Weintraub (principal investigator) will remain blinded throughout the study. I also agree to not break the blind. Dr. Weintraub has stated that as a result of my cooperation and ability to complete the study, I will be guaranteed to either keep my specific device or receive a specific known "active" device gratis. This currently sells commercially for $60.

Condition Intervention Phase
Chronic Low Back Pain Device: Flex Pad/Static Magnet Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Weintraub, Michael I., MD, FACP, FAAN:

Primary Outcome Measures:
  • The primary outcome measures will be reduction of chronic low back pain in comparison with prior baseline scores

Estimated Enrollment: 40
Study Start Date: December 2006
Estimated Study Completion Date: October 2007
  Show Detailed Description


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Chronic Low Back Pain

Exclusion Criteria:

  • No surgery on spine,
  • no tumor,
  • no pacemaker,
  • no pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00407615

Contact: Michael I. Weintraub, MD 914-941-0788

United States, New York
Dr. Michael I. Weintraub Recruiting
Briarcliff, New York, United States, 10510
Contact: Michael I. Weintraub, MD    914-941-0788   
Michael I. Weintraub MD 325 S. Highland Avenue Recruiting
Briarcliff, New York, United States, 10510
Contact: Michael I Weintraub, MD    914-941-0788   
Sub-Investigator: Susan Wolert, Data         
Sponsors and Collaborators
Weintraub, Michael I., MD, FACP, FAAN
Steven P. Cole, PhD.
Study Chair: Steve P Cole, PhD Research Design Inc.
  More Information Identifier: NCT00407615     History of Changes
Other Study ID Numbers: 12106
Study First Received: December 1, 2006
Last Updated: September 20, 2007

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms processed this record on August 17, 2017